| Overview |
| bsm-90229r-50µL |
| Ephrin A1 Recombinant Antbody Kit (KD-Validated) |
| WB |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Ephrin A1 |
| 1-50/205 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 1942 |
| P20827 |
| EFNA1; Ephrin A1; LERK1; Ephrin-A1; TNFAIP4; ECKLG; EPLG1; GMAN ; Gastric Cancer Metastasis Associated Long Noncoding RNA; EPH-Related Receptor Tyrosine Kinase Ligand 1; Tumor Necrosis Factor Alpha-Induced Protein 4; Immediate Early Response Protein B61; TNF Alpha-Induced Protein 4; LERK-1; Tumor Necrosis Factor Alpha-Induced Protein 4; Eph-Related Receptor Tyrosine Kinase Ligand 1; Epididymis Secretory Sperm Binding Protein; Ligand Of Eph-Related Kinase 1; EFL1; B61 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz